Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bioxytran Inc (BIXT)

Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 25,401
  • Shares Outstanding, K 173,982
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,280 K
  • 60-Month Beta -0.83
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BIXT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings $0.00 on 04/19/24
  • Latest Earnings Date 05/10/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1010 +29.60%
on 03/28/24
0.1505 -13.02%
on 04/24/24
+0.0159 (+13.83%)
since 03/22/24
3-Month
0.0950 +37.79%
on 02/06/24
0.1505 -13.02%
on 04/24/24
-0.0041 (-3.04%)
since 01/23/24
52-Week
0.0710 +84.37%
on 12/12/23
0.5351 -75.54%
on 05/01/23
-0.3441 (-72.44%)
since 04/24/23

Most Recent Stories

More News
While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants

EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END

NVAX : 4.15 (-0.95%)
PFE : 26.27 (-0.19%)
BNTX : 88.09 (-0.45%)
MRNA : 108.85 (+0.89%)
INO : 10.16 (-2.03%)
BIXT : 0.1309 (-10.34%)
Bioxytran Releases Positive Top-line Results from Phase 2 Trial of Galectin Antagonist on COVID-19 Patients in medRxiv Pre-print

Complete elimination of viral load in 100% of patients at day 7 vs 6% in placebo (p=.001) Complete elimination of viral load in 88% of patients at day 3 vs 0% in placebo (p=.001) Treated population experienced...

BIXT : 0.1309 (-10.34%)
Bioxytran Releases Positive Top-line Results from Phase 2 Trial of Galectin Antagonist on COVID-19 Patients in medRxiv Pre-print

/PRNewswire/ -- BIOXYTRAN, INC. (OTCQB: BIXT), (the "Company"), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and other viral...

BIXT : 0.1309 (-10.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

BioXyTran Inc. is a biotechnology company. It develops anti-necrosis drugs to treat medical conditions resulting from ischemia. The company's product pipeline consists of BXT-25 and BXT-252 which are in clinical stage. BioXyTran Inc. is based in Newton, United States.

See More

Key Turning Points

3rd Resistance Point 0.1901
2nd Resistance Point 0.1703
1st Resistance Point 0.1506
Last Price 0.1309
1st Support Level 0.1111
2nd Support Level 0.0913
3rd Support Level 0.0716

See More

52-Week High 0.5351
Fibonacci 61.8% 0.3578
Fibonacci 50% 0.3030
Fibonacci 38.2% 0.2483
Last Price 0.1309
52-Week Low 0.0710

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar